<DOC>
	<DOCNO>NCT00468806</DOCNO>
	<brief_summary>The purpose study look much new drug , GSK598809 bind specific protein brain much stay blood range different dos .</brief_summary>
	<brief_title>Study Safety , Blood Levels Brain Receptor Occupancy GSK598809 Using PET Imaging Health Males .</brief_title>
	<detailed_description />
	<criteria>Healthy male subject , define individual free clinically significant illness disease determine medical history ( include family ) , physical examination , laboratory study , test . Aged 2555 year inclusive , screen visit . Body weight &gt; 50 kg body mass index ( BMI ) 19.0 29.0 kg/m2 inclusive . Capable give informed consent comply study requirement timetable . Selfadministered Beck Depression Inventory II scale total score great 9 , suicide question score zero . Able read , comprehend record information . A signed date write informed consent obtain subject . The physician responsible considers subject unfit study base upon medical history , physical examination psychiatric history evaluation . History drug allergy opinion physician responsible contraindicates participation study . Participation clinical trial receive drug new chemical entity within 30 day 5 halflives , twice duration biological effect drug ( whichever longer ) prior first dose current study medication . Exposure four new chemical entity within 12 month prior first dose day . A screen ECG outside range specify protocol Pulse rate &lt; 55 &gt; 100 bpm OR systolic blood pressure &gt; 140 &lt; 100 OR diastolic blood pressure &gt; 90 &lt; 60 . History long QT syndrome ( personal family ) cardiac conduction disorder , clinically significant cardiac disease . An electrolyte value outside normal range prestudy screen . Subjects fall within normal reference range may include within study opinion Principal Investigator Medical Monitor compromise subject . Liver function test ( LFT ) elevate reference range prestudy screen remain elevated repeat LFT . Any clinically significant laboratory abnormality . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John'sWort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator sponsor medication interfere study procedure compromise subject safety . History regular alcohol consumption average &gt; 14 drinks/week men . One drink equivalent ( 12 g alcohol ) = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit ) within 6 month screen . Smokes smoke last 6 month . Donation 450 ml blood within 56 day dose . An unwillingness male subject abstain sexual intercourse pregnant lactate woman time administration study medication ( GSK598809 ) 90 day follow administration study medication unwillingness male subject use condom/spermicide addition female partner use another form contraception woman could become pregnant time administration study medication 90 day follow administration study medication . Current recent ( within one year ) gastrointestinal disease ; history malabsorption , esophageal reflux , irritable bowel syndrome ; frequent ( week ) occurrence heartburn ; surgical intervention ( e.g. , cholecysectomy ) would expect influence absorption drug . Any previous current psychiatric diagnosis list DSMIV Axis I II . Any history suicidal attempt , suicidal ideation behaviour . Chronic Hepatitis B C , evidence positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody . A positive test HIV . Past history drug abuse ( i.e . meeting DSM IV ICD 10 criterion substance dependence ) test positive urine drug abuse prestudy screen and/or prior dosing . Previous inclusion research and/or medical protocol involve nuclear medicine , PET radiological investigation significant radiation burden ( significant radiation burden define ICRP category IIb : No 10 mSv addition natural background radiation , previous 3 year include dose study ) . Family history cancer ( one firstdegree relative diagnose age 55 ) . History suffers claustrophobia feel unable lie still back PET camera period 2 hour . History presence neurological diagnosis ( limited include example , stroke , traumatic brain injury , epilepsy , space occupy lesion , multiple sclerosis , Parkinson 's disease , vascular dementia , transient ischemic attack , schizophrenia , major depression etc ) may influence outcome analysis scan result . Presence cardiac pacemaker electronic device ferromagnetic metal foreign body assess standard preMRI .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>PET scan</keyword>
	<keyword>Health Males</keyword>
</DOC>